Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. Our department will play a major role.

Pipette dripping into test tubes

The funding was awarded to the city's two National Institute for Health and Care Research (NIHR) Biomedical Research Centres (BRC). The BRCs bring together academics and clinicians to translate scientific breakthroughs into potential new treatments, diagnostics and medical technologies that benefit NHS patients.

The NIHR Oxford BRC, a partnership between the University of Oxford and Oxford University Hospitals (OUH) NHS Foundation Trust, will receive £86.6m over the next five years to fund 15 research themes.

The NIHR Oxford Health BRC, a partnership between the University and Oxford Health NHS Foundation Trust (OHFT), will receive £35.4m to support research across 11 themes. The award will create a network of centres of excellence in brain health across NHS and university sites in England.

The Oxford BRC - whose research covers a range of health themes including cancer, genomics, vaccines, diabetes, cardiovascular medicine and microbiology - was one of the five original BRCs created in 2007 and has just celebrated its 15th anniversary. The Oxford Health BRC was created in 2017 as a centre specialising in mental health and dementia.

Themes with NDCN involvement

NDCN has a major role to play in both BRCs:

NIHR Oxford BRC

  • Digital Health from Hospital to Home
  • Surgical Innovation, Technology and Evaluation
  • Preventive Neurology (led by Kevin Talbot, with sub-theme leaders Michele Hu and Peter Rothwell)
  • Imaging (major involvement through the Wellcome Centre for Integrative Neuroimaging)
  • Gene and Cell Therapy (co-led by Robert MacLaren)

NIHR Oxford Health BRC

  • Better Sleep (led by Colin Espie)
  • Brain Technologies (co-led by Heidi Johansen-Berg)
  • Dementia (co-led by Masud Husain)
  • Pain (led by David Bennett)

Similar stories

Study reveals association between diagnosis of a neuropsychiatric condition and severe outcome from COVID-19 infection, and other severe acute respiratory infections

New research from the University of Oxford has shown an increased risk of severe illness and death from both COVID-19 and other severe respiratory infections, such as influenza and pneumonia, among people with a pre-existing mental health condition.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

MSc Clinical and Therapeutic Neuroscience: Class 2021/22 Prizes

Congratulations to our MSc in Clinical and Therapeutic Neuroscience, Class of 2021/22 for successfully completing the course.

Visit from the Sir Jules Thorn Charitable Trust

Earlier this month, we were delighted to welcome the Director of the Sir Jules Thorn Charitable Trust, Richard Benson, and its Chair of Trustees, Liz Charal.